Myocardial protection during myocardial revascularization: Preductal®MR
| Autor: | Editorial Article |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2013 |
| Předmět: | |
| Zdroj: | Медицинский совет, Vol 0, Iss 9, Pp 98-100 (2013) |
| Druh dokumentu: | article |
| ISSN: | 2079-701X 2658-5790 |
| DOI: | 10.21518/2079-701X-2013-9-98-100 |
| Popis: | Myocardial revascularization procedures (coronary artery bypass surgery, percutaneous coronary intervention) raise the question of protecting the myocardium. Trimetazidine is an adequate method of myocardial protection. We discussed the use of trimetazidine in myocardial revascularization with Yuriy Mikhailovich Lopatin, MD, professor, head of subdepartment of cardiology and functional diagnostics at advanced medical training department of the Volgograd State Medical University. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|